131 related articles for article (PubMed ID: 8225907)
1. An enzyme-linked immunosorbent assay for the measurement of human IgA antibody responses to Epstein-Barr virus membrane antigen.
Durda PJ; Sullivan M; Kieff E; Pearson GR; Rabin H
Intervirology; 1993; 36(1):11-9. PubMed ID: 8225907
[TBL] [Abstract][Full Text] [Related]
2. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
3. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
Nadala EC; Tan TM; Wong HM; Ting RC
J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
[TBL] [Abstract][Full Text] [Related]
4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases.
Xu J; Ahmad A; Blagdon M; D'Addario M; Jones JF; Dolcetti R; Vaccher E; Prasad U; Menezes J
Int J Cancer; 1998 Oct; 79(5):481-6. PubMed ID: 9761116
[TBL] [Abstract][Full Text] [Related]
6. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection.
Tranchand-Bunel D; Gras-Masse H; Bourez B; Dedecker L; Auriault C
J Clin Microbiol; 1999 Jul; 37(7):2366-8. PubMed ID: 10364618
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
Khyatti M; Stefanescu I; Blagdon M; Menezes J
J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
[TBL] [Abstract][Full Text] [Related]
9. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
Chow KC; Ma J; Lin LS; Chi KH; Yen SH; Liu SM; Liu WT; Chen WK; Chang TH; Chen KY
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897
[TBL] [Abstract][Full Text] [Related]
10. [The purification and application of Epstein-Barr virus gp125].
Wang G; Pi G; Gu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
[TBL] [Abstract][Full Text] [Related]
11. A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.
Mathew A; Cheng HM; Sam CK; Joab I; Prasad U; Cochet C
Cancer Immunol Immunother; 1994 Jan; 38(1):68-70. PubMed ID: 8299121
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma.
Li RC; Du Y; Zeng QY; Tang LQ; Zhang H; Li Y; Liu WL; Zhong Q; Zeng MS; Huang XM
Oncotarget; 2016 Mar; 7(13):16372-83. PubMed ID: 27093005
[TBL] [Abstract][Full Text] [Related]
13. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
Chan SH; Soo MY; Gan YY; Fones-Tan A; Sim PS; Kaur A; Chew CT
Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay based on the 18-kilodalton matrix protein for diagnosis of primary EBV infection.
Chan KH; Luo RX; Chen HL; Ng MH; Seto WH; Peiris JS
J Clin Microbiol; 1998 Nov; 36(11):3359-61. PubMed ID: 9774594
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
Mendoza J; Rojas A; de la Rosa M; Amador JM; ExpĆ³sito J; Esquivias J
Med Clin (Barc); 1991 Nov; 97(16):609-11. PubMed ID: 1662737
[TBL] [Abstract][Full Text] [Related]
16. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
Zhu XX; Zeng Y; Wolf H
Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
[TBL] [Abstract][Full Text] [Related]
17. Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.
Foong YT; Cheng HM; Sam CK; Dillner J; Hinderer W; Prasad U
Int J Cancer; 1990 Jun; 45(6):1061-4. PubMed ID: 1693600
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins.
Littler E; Baylis SA; Zeng Y; Conway MJ; Mackett M; Arrand JR
Lancet; 1991 Mar; 337(8743):685-9. PubMed ID: 1672175
[TBL] [Abstract][Full Text] [Related]
20. Detection of IgA against Epstein-Barr virus BZLF-1 replication activator (ZEBRA) in sera of nasopharyngeal carcinoma patients with a recombinant ZEBRA protein.
Shu CH; Tu TY; Lin LS; Ro LH; Lo MS; Huang CH; Chen KY; Liu WT
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):350-5. PubMed ID: 10389292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]